94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CASE REPORT article
Front. Reprod. Health
Sec. Assisted Reproduction
Volume 7 - 2025 | doi: 10.3389/frph.2025.1559684
FIRST CLINICAL PREGNANCY AND DELIVERY ACHIEVED AFTER USING A NEW 3D IMAGING TECHNOLOGY FOR SPERM SELECTION: A CASE REPORT
Provisionally accepted- Barzilai Medical Center, Ashqelon, Israel
Objective: To report a case of a patient who, after experiencing recurrent failed implantations, underwent a novel technological intervention – using the Q300 device – which successfully led to a pregnancy and delivery of a healthy baby.Design: Case report.Setting: Barzilai University Medical Center. Patient (s): A 33-year-old woman with primary infertility experienced recurrent implantation failure (RIF), while her 32-year-old male partner was diagnosed with severe oligo‐astheno‐teratozoospermia (OTA) syndrome.Intervention: Using Q300 device for selection of the morphologically compliant sperm cells for intracytoplasmic sperm injection (ICSI). Main Outcome Measures: Successful pregnancy and delivery.Results: A unique case of clinical pregnancy and delivery involving a couple facing RIF and severe OTA. In this case, a new technology for sperm selection was used. The semen sample was examined using the Q300 device to choose WHO2021-morphologically compliant sperm cells for micro-injection. The resulting embryos were developed and then frozen. Later, a frozen-thawed embryo transfer was performed during the following natural menstrual cycle, leading to successful pregnancy and delivery.Conclusion: The utilization of this new 3D imaging technology underscores the evolving landscape of reproductive medicine and the potential it holds for transforming outcomes in challenging cases. By documenting such cases, we contribute to the ongoing dialogue to refine assisted reproductive technology (ART) protocols and improve reproductive outcomes for individuals facing similar challenges.
Keywords: Art, OTA, Sperm selection, ICSI, Blastocyst
Received: 13 Jan 2025; Accepted: 24 Feb 2025.
Copyright: © 2025 Michailov, Friedler and Saar-Ryss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yulia Michailov, Barzilai Medical Center, Ashqelon, Israel
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.